The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer

[1]  H. Höfler,et al.  Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3026 patients over a 25-year time period , 2008, Annals of surgery.

[2]  G. Sauter,et al.  Is It Time for a New TNM Classification in Esophageal Carcinoma? , 2008, Annals of surgery.

[3]  M. Gönen,et al.  Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer , 2007, Journal of Gastrointestinal Surgery.

[4]  M. Choti,et al.  Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. , 2007, Surgery.

[5]  A. Esterman,et al.  An Evaluation of Prognostic Factors and Tumor Staging of Resected Carcinoma of the Esophagus , 2007, Annals of surgery.

[6]  Michael A. Choti,et al.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience , 2006, Journal of Gastrointestinal Surgery.

[7]  M. Sierzega,et al.  The Ratio of Metastatic/Resected Lymph Nodes is an Independent Prognostic Factor in Patients With Node-positive Pancreatic Head Cancer , 2006, Pancreas.

[8]  H. Riediger,et al.  Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection , 2006, Journal of Gastrointestinal Surgery.

[9]  K. Campbell,et al.  Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinomad—part 3: Update on 5-year survival , 2005, Journal of Gastrointestinal Surgery.

[10]  Christopher H. Crane,et al.  Pancreaticoduodenectomy with vascular resection: margin status and survival duration , 2004, Journal of Gastrointestinal Surgery.

[11]  J. Izbicki,et al.  Mode of Spread in the Early Phase of Lymphatic Metastasis in Pancreatic Ductal Adenocarcinoma: Prognostic Significance of Nodal Microinvolvement , 2004, Annals of surgery.

[12]  Murray F. Brennan,et al.  Prognostic Nomogram for Patients Undergoing Resection for Adenocarcinoma of the Pancreas , 2004, Annals of surgery.

[13]  H. Jeekel.  Prognostic factors following curative resection for pancreatic adenocarcinoma. , 2004, Annals of surgery.

[14]  E. Ross,et al.  The Metastatic/Examined Lymph Node Ratio is an Important Prognostic Factor after Pancreaticoduodenectomy for Pancreatic Adenocarcinoma , 2004, The American surgeon.

[15]  H. Riediger,et al.  Risk factors for complications after pancreatic head resection. , 2004, American journal of surgery.

[16]  M. Martínez-González,et al.  Role of the Extended Lymphadenectomy in Gastric Cancer Surgery: Experience in a Single Institution , 2003, Annals of Surgical Oncology.

[17]  D. Lorenz,et al.  Long-term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25-Year Experience , 2003, World Journal of Surgery.

[18]  S. Fushida,et al.  Outcome of ratio of lymph node metastasis in gastric carcinoma , 2002, Annals of Surgical Oncology.

[19]  K. Campbell,et al.  Pancreaticoduodenectomy With or Without Distal Gastrectomy and Extended Retroperitoneal Lymphadenectomy for Periampullary Adenocarcinoma, Part 2: Randomized Controlled Trial Evaluating Survival, Morbidity, and Mortality , 2002, Annals of surgery.

[20]  D. Kerr,et al.  Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial , 2001, The Lancet.

[21]  K. Lillemoe,et al.  Resected adenocarcinoma of the pancreas— 616 patients: Results, outcomes, and prognostic indicators , 2000, Journal of Gastrointestinal Surgery.

[22]  K. Dhaene,et al.  Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group. , 1998, Annals of surgery.

[23]  G. Ohshio,et al.  Radical pancreatectomy for ductal cell carcinoma of the head of the pancreas , 1989, Cancer.

[24]  O. Ishikawa,et al.  Practical Usefulness of Lymphatic and Connective Tissue Clearance for the Carcinoma of the Pancreas Head , 1988, Annals of surgery.

[25]  T. Eberlein.  Adjuvant Chemotherapy With Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial , 2008 .

[26]  B. Eisenberg,et al.  Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas , 2003, International journal of gastrointestinal cancer.

[27]  Jeffrey E. Lee,et al.  Neoadjuvant Chemoradiotherapy for Adenocarcinoma of the Pancreas: Treatment Variables and Survival Duration , 2022 .